PL3759113T3 - Pochodne 10-(di(fenylo)metylo)-4-hydroksy-8,9,9a,10-tetrahydro-7h- pirolo[1’,2’:4,5]pirazyno[1,2-b]pirydazyno-3,5-dionowe i związki pokrewne jako inhibitory replikacji ortomyksowirusów do leczenia grypy - Google Patents
Pochodne 10-(di(fenylo)metylo)-4-hydroksy-8,9,9a,10-tetrahydro-7h- pirolo[1’,2’:4,5]pirazyno[1,2-b]pirydazyno-3,5-dionowe i związki pokrewne jako inhibitory replikacji ortomyksowirusów do leczenia grypyInfo
- Publication number
- PL3759113T3 PL3759113T3 PL19713572.6T PL19713572T PL3759113T3 PL 3759113 T3 PL3759113 T3 PL 3759113T3 PL 19713572 T PL19713572 T PL 19713572T PL 3759113 T3 PL3759113 T3 PL 3759113T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrrollo
- pyrazino
- pyridazine
- influenza
- tetrahydro
- Prior art date
Links
- YXKFWFPIHMMZAG-UHFFFAOYSA-N 1h-pyridazine-4,6-dione Chemical class O=C1CC(=O)C=NN1 YXKFWFPIHMMZAG-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 206010022000 influenza Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000010076 replication Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862636378P | 2018-02-28 | 2018-02-28 | |
| PCT/IB2019/051549 WO2019166950A1 (en) | 2018-02-28 | 2019-02-26 | 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3759113T3 true PL3759113T3 (pl) | 2025-01-20 |
Family
ID=65911219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19713572.6T PL3759113T3 (pl) | 2018-02-28 | 2019-02-26 | Pochodne 10-(di(fenylo)metylo)-4-hydroksy-8,9,9a,10-tetrahydro-7h- pirolo[1’,2’:4,5]pirazyno[1,2-b]pirydazyno-3,5-dionowe i związki pokrewne jako inhibitory replikacji ortomyksowirusów do leczenia grypy |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US11629149B2 (pl) |
| EP (2) | EP4467198A3 (pl) |
| JP (4) | JP7065989B2 (pl) |
| KR (3) | KR102521320B1 (pl) |
| CN (2) | CN118878544A (pl) |
| AU (1) | AU2019227250B2 (pl) |
| BR (1) | BR112020017121A2 (pl) |
| CA (1) | CA3092544A1 (pl) |
| CL (1) | CL2020002202A1 (pl) |
| CR (2) | CR20200372A (pl) |
| DK (1) | DK3759113T3 (pl) |
| EA (1) | EA202091696A1 (pl) |
| ES (1) | ES2993277T3 (pl) |
| FI (1) | FI3759113T3 (pl) |
| HR (1) | HRP20241522T1 (pl) |
| HU (1) | HUE069183T2 (pl) |
| IL (3) | IL276901B2 (pl) |
| LT (1) | LT3759113T (pl) |
| MX (2) | MX2020008959A (pl) |
| MY (1) | MY203207A (pl) |
| NZ (1) | NZ767072A (pl) |
| PE (1) | PE20210403A1 (pl) |
| PH (1) | PH12020500660A1 (pl) |
| PL (1) | PL3759113T3 (pl) |
| PT (1) | PT3759113T (pl) |
| SA (1) | SA520420046B1 (pl) |
| SG (1) | SG11202007718SA (pl) |
| SI (1) | SI3759113T1 (pl) |
| UA (1) | UA126253C2 (pl) |
| WO (1) | WO2019166950A1 (pl) |
| ZA (1) | ZA202005507B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2881776T3 (es) | 2016-03-08 | 2021-11-30 | Novartis Ag | Compuestos tricíclicos útiles para tratar las infecciones por ortomixovirus |
| JOP20170169A1 (ar) * | 2016-08-29 | 2019-01-30 | Novartis Ag | مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو |
| CN118878544A (zh) * | 2018-02-28 | 2024-11-01 | 诺华股份有限公司 | 作为正粘病毒复制抑制剂用于治疗流感的化合物 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2225112A (en) | 1938-07-09 | 1940-12-17 | Wright Aeronautical Corp | Air cleaner |
| GB8501542D0 (en) | 1985-01-22 | 1985-02-20 | Erba Farmitalia | 4 5 6 7-tetrahydro-imidazo(4 5-clpyridine derivatives |
| AUPM354694A0 (en) | 1994-01-27 | 1994-02-17 | Biota Scientific Management Pty Ltd | Chemical compounds |
| ES2572030T3 (es) | 2001-08-10 | 2017-07-19 | Shionogi & Co., Ltd. | Agente antiviral |
| JP2007524596A (ja) | 2003-02-28 | 2007-08-30 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 共結晶医薬組成物 |
| TW200510425A (en) | 2003-08-13 | 2005-03-16 | Japan Tobacco Inc | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
| TW200526635A (en) | 2003-12-22 | 2005-08-16 | Shionogi & Co | Hydroxypyrimidinone derivative having HIV integrase inhibitory activity |
| US20070161639A1 (en) | 2004-03-09 | 2007-07-12 | Philip Jones | Hiv integrase inhibitors |
| FR2901795A1 (fr) | 2006-05-30 | 2007-12-07 | Fourtillan Snc | Derives de pyrimidino[1',6'-1,2]pyrido[3,4-b]indoles et leur utilisation en therapeutique |
| CN102203100B (zh) | 2008-10-31 | 2014-08-27 | 盐野义制药株式会社 | 具有邻苯二酚基团的头孢菌素 |
| EP2412708A4 (en) | 2009-03-26 | 2014-07-23 | Shionogi & Co | SUBSTITUTED 3-HYDROXY-4-PYRIDONE DERIVATIVE |
| TWI518084B (zh) | 2009-03-26 | 2016-01-21 | 鹽野義製藥股份有限公司 | 哌喃酮與吡啶酮衍生物之製造方法 |
| US8927710B2 (en) | 2009-06-15 | 2015-01-06 | Shionogi & Co., Ltd. | Substituted polycyclic carbamoylpyridone derivative |
| RU2012131124A (ru) | 2009-12-23 | 2014-01-27 | Элан Фармасьютикалз, Инк. | Птеридиноны как ингибиторы polo-подобных киназ |
| TW201201813A (en) | 2010-03-31 | 2012-01-16 | Arqule Inc | Substituted benzo-pyrido-triazolo-diazepine compounds |
| US20120195857A1 (en) | 2010-08-12 | 2012-08-02 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
| DK2620436T3 (en) | 2010-09-24 | 2018-07-30 | Shionogi & Co | Substituted polycyclic carbamoylpyridone derivative prodrug |
| US9328075B2 (en) | 2011-05-05 | 2016-05-03 | St. Jude Children's Research Hospital | Pyrimidinone compounds and methods for treating influenza |
| RU2014113230A (ru) * | 2011-10-12 | 2015-11-20 | Шионоги Энд Ко., Лтд. | Полициклическое производное пиридона, обладающее ингибирующей активностью в отношении интегразы |
| JP6089108B2 (ja) | 2012-09-20 | 2017-03-01 | セルトリオン， インク． | ドラスタチン１０誘導体、その製造方法およびそれを含む抗癌剤組成物 |
| CA2894642A1 (en) | 2013-01-08 | 2014-07-17 | Savira Pharmaceuticals Gmbh | Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| AU2014308991B2 (en) | 2013-08-21 | 2019-02-14 | Janssen Biopharma, Inc. | Antiviral compounds |
| US10098913B2 (en) | 2013-09-11 | 2018-10-16 | University Of Southern California | Composition of stem cells having highly expressed FAS ligand |
| SI3030549T1 (sl) * | 2013-09-12 | 2019-08-30 | Janssen Biopharma, Inc. | Spojine piridazinona in njihove uporabe |
| MX377396B (es) | 2013-09-12 | 2025-03-10 | Janssen Biopharma Inc | Compuestos de azapiridona y usos de los mismos. |
| CN107074880A (zh) | 2014-07-07 | 2017-08-18 | 萨维拉制药有限公司 | 二氢吡啶并吡嗪‑1,8‑二酮和它们在治疗、改善或预防病毒疾病中的用途 |
| US10208045B2 (en) * | 2015-03-11 | 2019-02-19 | Alios Biopharma, Inc. | Aza-pyridone compounds and uses thereof |
| ES2881776T3 (es) | 2016-03-08 | 2021-11-30 | Novartis Ag | Compuestos tricíclicos útiles para tratar las infecciones por ortomixovirus |
| US10183945B2 (en) * | 2016-03-10 | 2019-01-22 | Alios Biopharma, Inc. | Method of preparing AZA-pyridone compounds |
| RU2019102647A (ru) | 2016-07-01 | 2020-08-03 | Г1 Терапьютикс, Инк. | Антипролиферационные средства на основе пиримидина |
| WO2018005863A1 (en) | 2016-07-01 | 2018-01-04 | G1 Therapeutics, Inc. | Pyrimidine-based compounds for the treatment of cancer |
| KR20190018469A (ko) * | 2016-08-10 | 2019-02-22 | 시오노기세야쿠 가부시키가이샤 | 치환된 다환성 피리돈 유도체 및 그의 프로드러그를 함유하는 의약 조성물 |
| JOP20170169A1 (ar) | 2016-08-29 | 2019-01-30 | Novartis Ag | مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو |
| JP2019059697A (ja) * | 2017-09-28 | 2019-04-18 | 塩野義製薬株式会社 | 置換された多環性ピリダジン誘導体およびそのプロドラッグ |
| US11247993B2 (en) * | 2018-01-17 | 2022-02-15 | Jiangxi Caishi Pharmaceutical Technology Co., Ltd. | Pyridone derivative, composition and use as antiviral drug thereof |
| CN110041327B (zh) | 2018-01-17 | 2022-01-21 | 江西彩石医药科技有限公司 | 吡啶酮衍生物、其组合物及作为抗流感病毒药物的应用 |
| CN118878544A (zh) * | 2018-02-28 | 2024-11-01 | 诺华股份有限公司 | 作为正粘病毒复制抑制剂用于治疗流感的化合物 |
| JP7282546B2 (ja) | 2018-02-28 | 2023-05-29 | 日本たばこ産業株式会社 | ４－メチルジヒドロピリミジノン化合物及びその医薬用途 |
| JP7089596B2 (ja) | 2018-02-28 | 2022-06-22 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | 肝がんの治療及び予防のための７位置換スルホンイミドイルプリノン化合物及び誘導体 |
| PE20210447A1 (es) | 2018-02-28 | 2021-03-08 | Japan Tobacco Inc | Compuestos de dihidropirimidinona o dihidrotriazinona fusionados con anillos saturados y su uso farmaceutico |
-
2019
- 2019-02-26 CN CN202410938055.0A patent/CN118878544A/zh active Pending
- 2019-02-26 AU AU2019227250A patent/AU2019227250B2/en active Active
- 2019-02-26 EP EP24195375.1A patent/EP4467198A3/en active Pending
- 2019-02-26 KR KR1020207027420A patent/KR102521320B1/ko active Active
- 2019-02-26 SG SG11202007718SA patent/SG11202007718SA/en unknown
- 2019-02-26 MY MYPI2020004423A patent/MY203207A/en unknown
- 2019-02-26 CN CN201980015931.XA patent/CN111801333B/zh active Active
- 2019-02-26 DK DK19713572.6T patent/DK3759113T3/da active
- 2019-02-26 EP EP19713572.6A patent/EP3759113B1/en active Active
- 2019-02-26 EA EA202091696A patent/EA202091696A1/ru unknown
- 2019-02-26 IL IL276901A patent/IL276901B2/en unknown
- 2019-02-26 ES ES19713572T patent/ES2993277T3/es active Active
- 2019-02-26 CR CR20200372A patent/CR20200372A/es unknown
- 2019-02-26 PE PE2020001286A patent/PE20210403A1/es unknown
- 2019-02-26 KR KR1020237006152A patent/KR20230031990A/ko not_active Ceased
- 2019-02-26 JP JP2020544932A patent/JP7065989B2/ja active Active
- 2019-02-26 UA UAA202005624A patent/UA126253C2/uk unknown
- 2019-02-26 KR KR1020247015694A patent/KR20240073143A/ko active Pending
- 2019-02-26 NZ NZ767072A patent/NZ767072A/en unknown
- 2019-02-26 BR BR112020017121-2A patent/BR112020017121A2/pt unknown
- 2019-02-26 SI SI201930859T patent/SI3759113T1/sl unknown
- 2019-02-26 US US16/975,784 patent/US11629149B2/en active Active
- 2019-02-26 WO PCT/IB2019/051549 patent/WO2019166950A1/en not_active Ceased
- 2019-02-26 PL PL19713572.6T patent/PL3759113T3/pl unknown
- 2019-02-26 FI FIEP19713572.6T patent/FI3759113T3/fi active
- 2019-02-26 MX MX2020008959A patent/MX2020008959A/es unknown
- 2019-02-26 CA CA3092544A patent/CA3092544A1/en active Pending
- 2019-02-26 HU HUE19713572A patent/HUE069183T2/hu unknown
- 2019-02-26 PT PT197135726T patent/PT3759113T/pt unknown
- 2019-02-26 CR CR20240350A patent/CR20240350A/es unknown
- 2019-02-26 HR HRP20241522TT patent/HRP20241522T1/hr unknown
- 2019-02-26 IL IL326515A patent/IL326515A/en unknown
- 2019-02-26 LT LTEPPCT/IB2019/051549T patent/LT3759113T/lt unknown
-
2020
- 2020-08-26 SA SA520420046A patent/SA520420046B1/ar unknown
- 2020-08-26 CL CL2020002202A patent/CL2020002202A1/es unknown
- 2020-08-27 PH PH12020500660A patent/PH12020500660A1/en unknown
- 2020-08-27 MX MX2023000084A patent/MX2023000084A/es unknown
- 2020-09-03 ZA ZA2020/05507A patent/ZA202005507B/en unknown
-
2022
- 2022-02-04 JP JP2022016352A patent/JP2022048391A/ja not_active Withdrawn
-
2023
- 2023-02-27 US US18/114,336 patent/US12071441B2/en active Active
- 2023-09-14 IL IL305957A patent/IL305957B1/en unknown
-
2024
- 2024-02-05 JP JP2024016007A patent/JP2024033009A/ja not_active Withdrawn
- 2024-07-03 US US18/764,058 patent/US20250034156A1/en active Pending
-
2025
- 2025-12-11 JP JP2025245272A patent/JP2026034569A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL305957B1 (en) | History of 10-(Di(phenyl)methyl)-4-hydroxy-8, 9, a9, 10-tetrahydro-h7-pyrrolo[1 ',2':4, 5]pyrazino[1, 2-b]pyridazine-3,5-dione and related compounds as inhibitors of orthomyxovirus replication for the treatment of influenza | |
| GEP20217248B (en) | 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh | |
| CY1122046T1 (el) | Δικυκλικα ετεροκυκλικα παραγωγα ως αναστολεις βρομοτομεων | |
| MX2019015431A (es) | Compuesto cíclico tipo cumarina como inhibidor de mek y su uso. | |
| CL2008002131A1 (es) | Compuestos heterociclos de amidas derivados de pirimidinas sustituidas por heterociclos y heterobiciclicos, inhibidores de la proteincinasa; composicion farmaceutica; y uso de los compuestos en el tratamiento de enfermedades proliferativas, neurologicas o neurodegenerativas, cardiovasculares, virosica o fungicas. | |
| DK3873884T3 (da) | 3-(quinolin-8-yl)-1,4-dihydropyrido[3,4-d]pyrimidin-2,4-dion-derivater som alpha4beta7-integrinhæmmere til behandling af inflammatoriske sygdomme | |
| WO2010068483A3 (en) | Mlk inhibitors and methods of use | |
| CL2007002166A1 (es) | Compuestos derivados de heterociclos de nitrogeno, antagonistas de los inhibidores de las proteinas de la apoptosis; sus composiciones farmaceuticas; y uso de dichos compuestos para el tratamiento del cancer. | |
| BR112016015838A8 (pt) | compostos heterocíclicos aromáticos, composição farmacêutica compreendendo os referidos compostos e produto de combinação | |
| MX381994B (es) | Inhibidor de janus quinasa. | |
| GEAP202215303A (en) | Chromane monobactam compounds for the treatment of bacterial infections | |
| PL3986561T3 (pl) | Pochodne pirydo[2,3-d]pirymidyny jako inhibitory replikacji ludzkiego wirusa niedoboru odporności | |
| WO2011149950A3 (en) | Bicyclic heteroaryl kinase inhibitors and methods of use | |
| IL283823A (en) | 7-phenoxy-n-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of alzheimer's disease | |
| EA201692268A1 (ru) | Ингибиторы фосфатидилинозитол-3-киназы | |
| EA201692249A1 (ru) | Ингибиторы фосфатидилинозитол-3-киназы | |
| SA519402103B1 (ar) | 1,6-naphthyridine مشتقات 1، 6 نفثيرايدين CDK4/6 على شكل مثبط | |
| CR20210666A (es) | Derivados heterocíclicos condensados | |
| EA201692557A1 (ru) | Хинолизиноновые производные в качестве ингибиторов pi3k | |
| ATE546452T1 (de) | Pyrazolopyrrolderivate als proteinkinaseinhibitoren | |
| EA201991355A1 (ru) | Производные имидазо[1,5-а]пиразина в качестве ингибиторов pi3kдельта | |
| BR112016005000A8 (pt) | combinação, kit de combinação, uso de uma combinação, composição farmacêutica, e, composto | |
| EP3849987C0 (en) | (S)-2-(4-(PHENYL)-6H-THIENO[3,2-F][1,2,4]TRIAZOLO[4,3-A] [1,4]DIAZEPIN-6 ACETATE DERIVATIVES -YL) TERT-BUTYL AND SIMILAR COMPOUNDS AS BRD4 BROMODOMAIN INHIBITORS FOR THE TREATMENT OF CANCER | |
| EA202090644A1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1,5-a]ПИРАЗИНА КАК ИНГИБИТОРЫ PI3K | |
| BR112016022974A2 (pt) | derivados de 2,4-tiazolidinadiona no tratamento de distúrbios do sistema nervoso central |